| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 4,393,000 | 4,348,000 | 4,577,000 | 4,920,000 | | Cost of Revenue | 1,399,000 | 1,525,000 | 1,738,000 | 1,907,000 | | | Gross Profit | 2,994,000 | 2,823,000 | 2,839,000 | 3,013,000 | | | Operating Expenses | | Research Development | 804,000 | 850,000 | 893,000 | 906,000 | | Selling General and Administrative | 1,493,000 | 1,615,000 | 1,661,000 | 1,871,000 | | Non Recurring | 75,000 | 111,000 | 101,000 | 94,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 622,000 | 247,000 | 184,000 | 142,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21,000 | (24,000) | 176,000 | 144,000 | | Earnings Before Interest And Taxes | 1,043,000 | 649,000 | 794,000 | 779,000 | | Interest Expense | 109,000 | 122,000 | 136,000 | 278,000 | | Income Before Tax | 934,000 | 527,000 | 658,000 | 501,000 | | Income Tax Expense | 129,000 | (61,000) | 69,000 | 66,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 805,000 | 588,000 | 589,000 | 435,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 805,000 | 588,000 | 589,000 | 435,000 | | Preferred Stock And Other Adjustments | (38,000) | (37,000) | (38,000) | (37,000) | | | Net Income Applicable To Common Shares | $767,000 | $551,000 | $551,000 | $398,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
